I mmune-mediated encephalitis with autoantibodies directed against synaptic proteins has become an important component of the differential diagnosis of patients with encephalitis. Current estimates suggest that a substantial proportion of patients once suspected to have viral encephalitis in fact have an autoimmune etiology for their symptoms.
I mmune-mediated encephalitis with autoantibodies directed against synaptic proteins has become an important component of the differential diagnosis of patients with encephalitis. Current estimates suggest that a substantial proportion of patients once suspected to have viral encephalitis in fact have an autoimmune etiology for their symptoms. 1 Additional autoantigen targets continue to be identified, and the phenotypic spectrum associated with autoimmune encephalitis continues to expand. We describe a 3-year-old patient who presented with acuteonset confusion, opsoclonus, chorea, and intractable seizures. Neuroimaging disclosed involvement of the brainstem, basal ganglia, and hippocampi. γ-Aminobutyric acid type B (GABA B ) receptor autoantibodies were identified in the serum and cerebrospinal fluid (CSF). Despite immunomodulating therapy, the patient died of overwhelming sepsis. To our knowledge, this is the first description of a pediatric patient with GABA B receptor autoantibodies. The presence of opsoclonus, ataxia, and chorea expands the clinical phenotype and indicates that GABA B receptor autoimmunity should be considered in cases of pediatric encephalitis.
Report of a Case
A previously healthy 3-year-old boy developed confusion and lethargy at home during the course of a single day, prompting his parents to seek medical attention. His initial examination disclosed opsoclonus, dystonic movements of the tongue, ataxia, and chorea affecting the limbs and trunk. OBSERVATIONS We describe a 3-year-old boy who presented with a mixed movement disorder (opsoclonus, ataxia, and chorea) as well as seizures refractory to treatment. His seizures required continuous pentobarbital sodium infusion to be controlled. Despite treatment with intravenous corticosteroids and immunoglobulins, the patient ultimately died of overwhelming sepsis.
CONCLUSIONS AND RELEVANCE To our knowledge, this report represents the first pediatric case of GABA B -associated encephalitis. Our patient presented with encephalopathy, refractory seizures, and a mixed movement disorder rather than limbic encephalitis. γ-Aminobutyric acid type B receptor autoimmunity deserves consideration in pediatric patients presenting with encephalitis.
tineuronal nuclear antibody 1, Purkinje cell cytoplasmic antibody 1, amphiphysin antibody, antineuronal nuclear antibody 2, Purkinje cell cytoplasmic antibody type Tr, Purkinje cell cytoplasmic antibody 2, antineuronal nuclear antibody 3, collapsin response-mediator protein 5 IgG, anti-glial/ neuronal nuclear antibody 1, voltage-gated calcium channel antibody, glutamic acid decarboxylase 65, and N-methyl-Daspartate receptor antibody, was negative. Neuroimaging demonstrated multifocal diffusion-weighted imaging hyperintensities within the brainstem and cerebellum without corresponding apparent diffusion coefficient restriction, leading to a working diagnosis of rhomboencephalitis ( Figure 1) . Subsequent imaging showed evolution of these lesions to T2/ fluid-attenuated inversion recovery hyperintensity, with involvement of the basal ganglia. Electroencephalography demonstrated diffuse delta range slowing and bioccipital spike-wave discharges with rapid secondary generalization. The patient's electrographic seizures persisted despite administration of multiple anticonvulsants. Seizures were eventually controlled with a continuous infusion of pentobarbital sodium, but status epilepticus recurred each time a wean was attempted. The patient developed worsening cerebral edema, and a decompressive posterior craniectomy was performed. At this time, a cerebellar biopsy specimen was also obtained. This demonstrated widespread astrogliosis and microglial activation with Purkinje and granule cell loss (Figure 2) . A CD3 + T-cell infiltrate was also observed. Bacterial and viral culture of biopsy tissue as well as 16S ribosomal RNA polymerase chain reaction for bacteria, acid-fast bacilli, fungus, and mold did not detect any pathogens. The patient was treated with high-dose intravenous corticosteroids and intravenous immunoglobulin without clear benefit. A search for an occult tumor was not performed. Despite intensive supportive care and aggressive seizure management, the patient developed overwhelming sepsis and died 4 weeks after his initial presentation. The parents declined an autopsy.
Two years after the patient's initial presentation, testing of archived serum and CSF identified diffuse reactivity to rat neuropil with prominent reactivity in the cerebellum, thalamus, and hippocampus. Follow-up studies using HEK293 cells transfected with GABA B1 and GABA B2 were performed. Transfected cells were fixed in 4% paraformaldehyde, permeabilized with 0.1% Triton-X100, and incubated overnight at 4°C with the patient's CSF (neat) and guinea pig GABA B1 or GABA B2 polyclonal antibody. AlexaFluor secondary antibodies were used for visualization, and colocalization was performed using an ImageJ-based macro. These studies indicated high-titer anti-GABA B1 receptor autoantibodies. patients have been adults with limbic encephalitis and seizures, and about half of the cases have been paraneoplastic in origin, with small cell lung cancer being the most commonly identified neoplasm. To our knowledge, our patient is the first pediatric patient described with this new form of autoimmune encephalitis. Our patient's case was not associated with an identified tumor (although an exhaustive search for an occult neoplasm was not performed) or a recognized preceding infection. In addition, although mesial temporal lobe involvement was demonstrable on the patient's neuroimaging, he did not present with classic signs and symptoms of limbic encephalitis (amnesia, psychosis, or agitation), although his young age complicated assessment. Severe, refractory seizures dominated the clinical course in our patient, similar to previously described adult patients. Although the patient's seizures did not respond to immunomodulating treatments, it is not known whether more aggressive immunosuppressive therapy may have led to a treatment response. 5, 6 The opsoclonus, chorea, and lingual dystonia in our patient are novel phenotypic features (1 adult patient presented with orobuccolingual dyskinesias without limb involvement 2 ). Such abnormal hyperkinetic movements are consistent with the role of GABA B receptors in modulating dopaminergic neurotransmission 7 and suggest that this entity should be considered in the differential diagnosis of autoimmune movement disorders 8 and perhaps even in cases of atypical opsoclonus-myoclonus-ataxia syndrome. + microglial activation is present (3,3′-diaminobenzidine, original magnification ×20).
